Co-Authors
This is a "connection" page, showing publications co-authored by TIMOTHY J MCDONNELL and LORETTA NASTOUPIL.
Connection Strength
0.290
-
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis. Blood. 2024 Nov 07; 144(19):2063-2066.
Score: 0.062
-
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL. Blood Adv. 2024 08 27; 8(16):4414-4422.
Score: 0.061
-
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. Am J Hematol. 2024 03; 99(3):408-421.
Score: 0.059
-
A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL. Blood Adv. 2023 04 11; 7(7):1137-1145.
Score: 0.056
-
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma. J Clin Oncol. 2023 02 01; 41(4):745-755.
Score: 0.053